Calcium channels in glioma

doi:10.3760/cma.j.issn.1673-422X.2014.08.007

Abstract

Abstract: Calcium channels express abnormally in glioma, and play a key role in the physiological functions of glioma such as tumorigenesis, proliferation, metastasis and angiogenesis. Researches show that low or high expressions of different types of calcium channels have influence on the development of glioma and cellcycle redistribution. Such calcium channels may represent new targets in treating glioma,which provide new ideas for controlling glioma.

Key words: Glioma, Calcium channels, Calcium channel blockers

Liu Yang, Wamg Yanming. Calcium channels in glioma[J]. Journal of International Oncology, 2014, 41(8): 579-582.

References

［1］ Prevarskaya N, Skryma R, Shuba Y. Targeting Ca2+ transport in cancer: close reality or long perspective?［J］. Expert Opin Ther Targets, 2013, 17(3): 225-241. ［2］ Taylor JT, Zeng XB, Pottle JE, et al. Calcium signaling and Ttype calcium channels in cancer cell cycling［J］. World J Gastroenterol, 2008, 14(32): 4984-4991. ［3］ Lu F, Chen H, Zhou C, et al. Ttype Ca2+ channel expression in human esophageal carcinomas: a functional role in proliferation［J］. Cell Calcium, 2008, 43(1): 4958. ［4］ Ohkubo T, Yamazaki J. Ttype voltageactivated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF7 human breast cancer cells［J］. Int J Oncol, 2012, 41(1): 267-275. ［5］ Li W, Zhang SL, Wang N, et al. Blockade of Ttype Ca2+ channels inhibits human ovarian cancer cell proliferation［J］. Cancer Invest, 2011, 29(5): 339-346. ［6］ Zhang Y, Zhang J, Jiang D, et al. Inhibition of Ttype Ca2+ channels by endostatin attenuates human glioblastoma cell proliferation and migration［J］. Br J Pharmacol, 2012, 166(4): 1247-1260. ［7］ Valerie NC, Dziegielewska B, Hosing AS, et al. Inhibition of Ttype calcium channels disrupts Akt signaling and promotes apoptosis in glioblastoma cells［J］. Biochem Pharmacol, 2013, 85(7): 888-897. ［8］ Sheehan JP, Xu Z, Popp B, et al. Inhibition of glioblastoma and enhancement of survival via the use of mibefradil in conjunction with radiosurgery［J］. J Neurosurg, 2013, 118(4): 830-837. ［9］ Keir ST, Friedman HS, Reardon DA, et al. Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model［J］. J Neurooncol, 2013, 111(2): 97-102. ［10］ Santoni G, Farfariello V. TRP channels and cancer: new targets for diagnosis and chemotherapy［J］. Endocr Metab Immune Disord Drug Targets, 2011, 11(1): 54-67. ［11］ Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer［J］. Biochim Biophys Acta, 2007, 1772(8): 937-946. ［12］ Gkika D, Prevarskaya N. Molecular mechanisms of TRP regulation in tumor growth and metastasis［J］. Biochim Biophys Acta, 2009, 1793(6): 953-958. ［13］ Santoni G, Farfariello V, Amantini C. TRPV channels in tumor growth and progression［J］. Adv Exp Med Biol, 2011, 704: 947-967. ［14］ Bomben VC, Sontheimer HW. Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas［J］. Cell Prolif, 2008, 41(1): 98-121. ［15］ Bomben VC, Sontheimer H. Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas［J］. Glia, 2010, 58(10): 1145-1156. ［16］ Malarkey EB, Ni Y, Parpura V. Ca2+ entry through TRPC1 channels contributes to intracellular Ca2+ dynamics and consequent glutamate release from rat astrocytes［J］. Glia, 2008, 56(8): 821-835. ［17］ Ding X, He Z, Zhou K, et al. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma［J］. J Natl Cancer Inst, 2010, 102(14): 1052-1068. ［18］ Chigurupati S, Venkataraman R, Barrera D, et al. Receptor channel TRPC6 is a key mediator of Notchdriven glioblastoma growth and invasiveness［J］. Cancer Res, 2010, 70(1): 418-427. ［19］ Amantini C, Mosca M, Nabissi M, et al. Capsaicininduced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation［J］. J Neurochem, 2007, 102(3): 977-990. ［20］ Stock K, Kumar J, Synowitz M, et al. Neural precursor cells induce cell death of highgrade astrocytomas through stimulation of TRPV1［J］. Nat Med, 2012, 18(8): 1232-1238. ［21］ Nabissi M, Morelli MB, Amantini C, et al. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fasinduced apoptosis in ERKdependent manner［J］. Carcinogenesis, 2010, 31(5): 794-803. ［22］ Nabissi M, Morelli MB, Santoni M, et al. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents［J］. Carcinogenesis, 2013, 34(1): 48-57.

[1]	Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei. Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction [J]. Journal of International Oncology, 2024, 51(4): 193-197.
[2]	Xiao Nan, Sun Pengfei. Research progress of oxidative stress in the sensitivity of chemoradiotherapy for gliomas [J]. Journal of International Oncology, 2022, 49(6): 357-361.
[3]	Zhu Yishuo, Cui Yujie, Liu Qi, Li Jun, Fan Yuechao. Analysis of risk factors and prediction model establishment for early postoperative recurrence in glioma patients [J]. Journal of International Oncology, 2022, 49(2): 79-83.
[4]	Kong Chunyu, Sun Pengfei. SLC7A11 and glioma [J]. Journal of International Oncology, 2022, 49(10): 604-607.
[5]	Guo Shihao, Ren Yeqing, Guo Geng. Molecular mechanism of vasculogenic mimicry in brain glioma [J]. Journal of International Oncology, 2021, 48(6): 362-365.
[6]	Wang Xianwei, Shi Meiyan, Wang Fengqin, Qi Fu, Wang Chaozhe, Zhou Fei. Roles of TSA upregulation miR-4298 targeting inhibition of PADI4 expression in inducing U251 cells apoptosis [J]. Journal of International Oncology, 2021, 48(4): 193-199.
[7]	Sun Yanqi, Ren Yeqing, Guo Geng. Mechanism of inhibitory effect of interferon and its related signal pathway on the invasion of glioma [J]. Journal of International Oncology, 2021, 48(3): 172-175.
[8]	Zhao Congxuan, Yu Tao. Mining and prediction of glioma-related genes [J]. Journal of International Oncology, 2020, 47(5): 293-296.
[9]	Nan Yang, Zhong Yue. New research advances of long non-coding RNA in glioma [J]. Journal of International Oncology, 2020, 47(2): 98-102.
[10]	Zhang Wen, Song Qibin, Hu Weiguo. Clinical application of multimodal magnetic resonance imaging in glioma [J]. Journal of International Oncology, 2020, 47(11): 686-690.
[11]	Chen Liang, Qin Jun, Lei Junrong, Liu Jun, Wang Lu. miR-1254 inhibits the proliferation and invasion of glioma cells by targeting CSF-1 [J]. Journal of International Oncology, 2020, 47(10): 577-584.
[12]	Zhang Qianhui, Zhang Yang, Su Weipeng, Zhang Song′an, Liu Pan, Zhao Huarong. Expressions of LSD1, MGMT and Ki-67 in high-grade glioma and their influences on prognosis [J]. Journal of International Oncology, 2019, 46(9): 519-525.
[13]	Yi Lin, Qiu Shi. Anti-tumor effect and mechanisms of shikonin on gliomas [J]. Journal of International Oncology, 2019, 46(8): 489-491.
[14]	Yu Xuejuan, An Hongwei, Sun Yamei, Jiang Zheng, Zhang Xuehai, Yang Wenjing, Zhang Wei. Expressions of MMP2, TIMP2, Ki-67 and P53 in glioma tissues and their significance [J]. Journal of International Oncology, 2019, 46(12): 718-722.
[15]	Lu Di, Zhang Jundong, Guo Geng, Wang Xiaogang. Research progress of interferon induced glioma cell apoptosis [J]. Journal of International Oncology, 2018, 45(7): 432-435.